ArticleJournal of clinical imaging science2025
Percutaneous n-butyl cyanoacrylate glue embolization combined with arterial embolization for extracranial arteriovenous malformations.
Article in Journal of clinical imaging science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Staged, office-based multifaceted cure of a previously mismanaged, life-threatening gluteal arteriovenous malformation using venaseal cyanoacrylate for embolization.Journal of vascular surgery cases and innovative techniques · 2026Article
- N-butyl cyanoacrylate glue: the most misunderstood hero in interventional radiology.CVIR endovascular · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Congenital arteriovenous malformations (AVMs) are characterized by abnormal connections between arteries and veins, often presenting challenges in treatment due to their complex vascular structure. Endovascular therapies, including embolization techniques, have become integral in managing AVMs, yet optimal treatment strategies remain under investigation. This retrospective study aimed to evaluate the safety and efficacy of percutaneous glue embolization of n-butyl cyanoacrylate (nBCA) combined with arterial embolization in treating extracranial AVMs. Material and Methods: This retrospective study included 11 patients with extracranial AVMs who underwent percutaneous injection of nBCA glue embolization combined with arterial embolization at our institution between May 2015 and October 2023. Angiographic classification was performed using the Cho-Do vascular imaging system and the Schobinger classification system to categorize the AVMs. Treatment efficacy was assessed based on the percentage of vessel occlusion observed in angiography or imaging studies. The occurrence of major and minor complications was also evaluated. Results: Eleven patients received 16 treatments, involving a combination of arterial and percutaneous embolization techniques. Five cases achieved complete recovery, while four cases showed significant improvement, resulting in an overall treatment success rate of 81.8%. Favorable outcomes were observed in terms of symptom alleviation and lesion occlusion. Adverse events were minimal, with transient pain and edema being the most common postoperative complaints. Only one case of mild post-operative complication occurred. Conclusion: Percutaneous glue embolization combined with arterial embolization proves to be a safe and effective treatment modality for extracranial AVMs, with acceptable rates of complications and favorable treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.